How Do GLP-1 Drugs Like Ozempic Work? A Science-Backed Review of the Obesity Revolution [Updated 2026]

For the vast majority of human history, calorie-dense foods were rare. Our ancestors evolved a biological drive to seek out sugar, fat, and salt as a survival mechanism. However, the modern world has transformed rapidly, creating an environment where highly processed, hyperpalatable foods are abundant and engineered to trigger our reward centers. This mismatch between our ancient biology and the current food landscape is a primary driver of the global obesity crisis, which now affects over 1 billion people.

Obesity is not merely a matter of self-control; it is a chronic medical condition characterized by the accumulation of unhealthy body fat. Small daily caloric excesses, often as minor as half a snack bar beyond maintenance levels, compound over years to result in significant weight gain. Because the body naturally defends its highest weight baseline, traditional dieting often fails as the metabolism slows and hunger signals intensify in an attempt to regain lost fat.

Our bodies manage hunger through a complex orchestra of hormones. One critical player is Glucagon-Like Peptide 1 (GLP-1), a hormone released after eating that signals the pancreas to produce insulin and tells the brain the stomach is full. In a natural state, GLP-1 lasts only about two minutes before being broken down. Modern drugs like Ozempic and Mounjaro are synthetic versions of this hormone that stay active in the bloodstream for up to a week.

These GLP-1 agonists work by magnifying the signal of fullness. By maintaining a constant presence, they effectively silence the constant urge to eat known as food noise. This allows individuals to feel satisfied with smaller portions and reduces the frequency of snacking. For many, this feels like a psychological relief, as it removes the need to constantly expend willpower to resist hunger signals.